| Wednesday, October 28, 2009 |
| 7:00 AM–12:00 NOON |
|
| |
Registration |
|
|
| 7:00 AM–9:00 AM |
|
|
Committee Meetings |
|
|
2010 Program Committee
(second meeting)
|
Chairperson: Jeffrey L. Schwartz, University of Washington |
|
| 7:30 AM–9:00 AM |
|
|
Web Site Committee |
Chairpersons: Martina L. Veigl, Case Western Reserve University and Barry N. Ford, Defense Research and Development |
|
| 8:30 AM–5:30 PM |
|
| |
Networking Room Open |
|
|
| 9:00 AM–11:00 AM |
|
|
Symposium 14
Chemical and Radiation Induced Persistent and Untargeted Genetic Instability
|
Chairperson: Robert H. Schiestl, UCLA School of Medicine and Public Health |
| 9:00 AM – 9:30 AM |
Ionizing Radiation Induces Microhomology-Mediated End-Joining In Trans in Yeast and Mammalian Cells
Speaker: Robert H. Schiestl, UCLA School of Medicine and Public Health |
| 9:30 AM–10:00 AM |
Mechanisms of Long Term Accumulation of Mutations: Clonal Expansion and Epigenetic Changes
Speaker: Bevin P. Engelward, Massachusetts Institute of Technology |
| 10:00 AM–10:30 AM |
Germ Cells Mediate Untargeted Mutagenesis in the Maternal
Genome of Progeny
Speaker: Richard N. Winn, University of Georgia |
| 10:30 AM – 11:00 AM |
Radiation-Induced Persistent Genomic Instability
Speaker: Charles L. Limoli, University of California, Irvine |
| 9:00 AM–11:00 AM |
|
|
Symposium 15
Women in Environmental Mutagen Society Special Interest Group Women’s Health Issues: Diagnosis and Treatment in the 21st Century
Contributing Sponsors: National Institute of Environmental Health Sciences, NIH and Office of Research in Women's Health, NIH |
Chairpersons: Kristine L. Witt, National Institute of Environmental Health Sciences, NIH, Glenda J. Gentile, University of Arizona, Janice M. Pluth, Lawrence Berkeley National Laboratory, and Ofelia A. Olivero, National Cancer Institute, NIH |
| 9:00 AM– 9:35 AM |
Challenges of Epidemiologic Research in the Genomic Era: The Example of Ovarian Cancer
Speaker: Patricia G. Moorman, Duke University |
| 9:35 AM–10:10 AM |
Novel Epigenetic Biomarkers for Early Detection of Breast Cancer
and Prediction of Treatment Responses: from Bench to Bedside
Speaker: Olga Kovalchuk, University of Lethbridge |
| 10:10 AM–10:45 AM |
Obesity, Vitamin Supplementation and Biomarkers of Oxidative Stress and Cardiovascular Disease
Speaker: Nina T. Holland, University of California, Berkeley |
| 10:45 AM–11:00 AM |
PALB2 Physically and Functionally Connects BRCA1 and BRCA2 into a Pathway of Homologous Recombination
Zhang F, Fan Q, Ren K, Andreassen PR. Cincinnati Children's Research Foundation, Cincinnati, OH, United States |
| |
|
|
| 11:00 AM–12:00 NOON |
|
|
Plenary Lecture 5
Mending Human Genes
EMS Award Recpient
Lecturer: James E. Cleaver, University of California, San Francisco |
|
|
| 12:00 NOON–1:15 PM |
|
|
Lunch on Own |
|
| |
| 12:10 PM–1:15 PM |
|
|
Town Hall Meeting
EMS Strategic Plan and Implementation |
|
| |
| 1:15 PM–3:15 PM |
|
|
Platform Session 3
Risk/Regulation
Platform presenter designated by underlined author. |
Chairperson: Richard D. Wood, The University of Texas MD Anderson Cancer Center |
| 1:15 PM–1:30 PM |
Accelerated Tumorigenesis in the Absence of DNA Polymerase Zeta
Wittschieben JP, Patil V, Glushets V, Robinson LJ, Wood RD |
| 1:30 PM–1:45 PM |
CYPD6*16 Testing to Accurately Detect Poor Metabolizers
Phillips SL, Clark LS |
| 1:45 PM–2:00 PM |
Polyploidy-Induction by Dihydroxylated Monochloro-Biphenyls and Structure-Activity-Relationship?
Flor S, Ludewig G |
| 2:00 PM–2:15 PM |
Spectrum of Chromosomal Aneuploidy, Benzene Exposure and Leukemia Risk
Zhang L, Lan Q, Guo W, Hubbard A, Li G, Rappaport SM, Ji Z, Shen M, Vermeulen R, Yin S, Rothman N, Smith MT |
| 2:15 PM–2:30 PM |
Genotoxicity Evaluation of Hepatocarcinogens in Rat Liver Tissue by Systems Toxicology Approach
Chung Y-S, Yum YN, Kim JE, Koo KH, Lee WS, Park SN |
| 2:30 PM–2:45 PM |
Germline Mutation in Mice Exposed to Mainstream and Sidestream Tobacco Smoke
Marchetti F, Rowan-Carroll A, Berndt-Weis ML, Polyzos A, Yauk C |
| 2:45 PM–3:00 PM |
Molecular and Genetic Factors Influence on DNA Repair Efficiency and Health Hazard
Cebulska-Wasilewska A |
| 3:00 PM–3:15 PM |
Human Risk by the Environmental Exposure to Benzo[a]pyrene
Sram RJ, Binkova B, Beskid O, Milcova A, Rossner P, Rossnerova A, Solansky I, Topinka J |
| |
| 1:15 PM–3:15 PM |
|
|
Platform Session 4
Genetic Toxicology/Environmental Mutagenesis
Platform presenter designated by underlined author. |
Chairpersons: Robert H. Heflich, National Center for Toxicological Research, U.S. FDA and Helena Groot de Restrepo, Universidad de los Andes |
| 1:15 PM–1:30 PM |
Comparative DNA Damage and Repair Kinetics Study in Mammalian Cells by Chloro-, Bromo-, and Iodoacetic Acid
Komaki Y, Pals J, Wagner E, Marinas B, Plewa MJ |
| 1:30 PM–1:45 PM |
The Somatic Microindels in Human Cancer Are Highly Error-Prone and Suggest the Involvement of an As Yet Uncharacterized Repair Pathway
Sommer S, Gonzalez K, Scaringe W |
| 1:45 PM–2:00 PM |
Elucidating the Functional Consequences of the Trichloroethylene Associated Von-Hippel Lindau Tumor Suppressor Gene Mutation Using a Genetically Engineered Model System
DeSimone MC, Rathmell WK, Threadgill DW |
| 2:00 PM–2:15 PM |
European Hot Spot of Air Pollution by PM2.5 and B[a]P: Ostrava, Czech Republic
Sram RJ, Milcova A, Pastorkova A, Rossner, Jr. P, Rossnerova A, Solansky I, Svecova V, Topinka J |
| 2:15 PM–2:30 PM |
GADD45a-GFP Test Results from ECVAM Recommended Lists of Compounds for the Assessment of New or Improved Genotoxicity Tests
Walmsley RM, Tate M, Cahill P, Birrell L, Hughes C, Jagger C, Knight A, Billinton N |
| 2:30 PM–2:45 PM |
Detecting PIG-A Gene Mutation in Human Red Blood Cells
Dobrovolsky VN, Bigger CAH, Elespuru RK, Robison TW, Heflich RH |
| 2:45 PM–3:00 PM |
Occupational Exposure to Organic Solvents: Biomarkers of Exposure, Effect and Susceptibility
Varona M, Torres CH, Diaz S, Patiño RI, Albores A, Narvaez DM, Groot H |
| 3:00 PM–3:15 PM |
Future Application of Genetic Toxicity Assays
Elespuru RK, Agarwal R, Atrakchi A, Bigger CAH, Heflich RH, Jagannath DR, Levy DD, Moore MM, Ouyang Y, Robison TW, Cimino MC, Dearfield KL |
| |
| 3:30 PM–5:30 PM |
|
|
Symposium 16
Nanotechnology: An Insight on the Toxicology of Nanoparticles
|
Chairpersons: Patricia A. Escobar, Boehringer Ingelheim, Inc. Pharmaceuticals and David M. DeMarini, U.S. Environmental Protect Agency |
| 3:30 PM–4:00 PM |
Regulatory Issues Surrounding Nanoparticles
Speaker: Penelope Rice, CFSA, U.S. Food and Drug Administration |
| 4:00 PM–4:45 PM |
Overview on the Genotoxicity of Nanoparticles
Speaker: Micheline Kirsch-Volders, Vrije Universiteit Brussels |
| 4:45 PM–5:15 PM |
Issues Surrounding the Testing of Nanoparticles for Genotoxicity
Speaker: Fanqing Frank Chen, Lawrence Berkeley National Laboratory |
| 5:15 PM–5:30 PM |
Aneugenic and Clastogenic Effects of Amorphous Silica Nanoparticles in A549 Human Lung Carcinoma Cells: Size Matters?
Gonzalez L1, Thomassen L2, Plas G1, Rabolli V3, Napierska D2, Decordier I1, Hoet P2, Martens J2, Lison D3, Kirsch-Volders M1. 1Vrije Universiteit Brussel, Brussels, Belgium, 2Katholieke Universiteit Leuven, Leuven, Belgium, 3Université Catholique de Louvain, Brussels, Belgium |
| 3:30 PM–5:30 PM |
|
|
Symposium 17
Use of DNA Adduct Data in Risk Assessment: Context is Everything!
Contributing Sponsors: American Chemical Council Ethylene Oxide Panel Toxicology Research Task Group, American Chemical Council Olefins Panel Ethylene/Propylene Work Group (Olefins Panel E/PWG), and ILSI-HESI DNA Adducts Project Committee |
Chairpersons: Lynn H. Pottenger, The Dow Chemical Company and Rita Schoeny, U.S. Environmental Protection Agency |
| 3:30 PM–3:45 PM |
Overview/Objectives of ILSI-HESI DNA Adduct Project Committee
Speaker: Lynn H. Pottenger, The Dow Chemical Company |
| 3:45 PM–4:05 PM |
Creating Context for the Use of DNA Adduct Data in Risk Assessment
Speaker: Rita Schoeny, U.S. Environmental Protection Agency |
| 4:05 PM–4:25 PM |
DNA Adduct Measurements: Promise and Pitfalls
Speaker: Matthew W. Himmelstein, DuPont Haskell Global Center for
Health and Environmental Sciences |
| 4:25 PM–4:45 PM |
Biomarkers of Exposure and Effect: Implications for Risk Assessment
Speaker: James A. Swenberg, University of North Carolina |
| 4:45 PM–5:10 PM |
Case Study Examples
Speaker: Elizabeth Martin, AstraZeneca |
| 5:10 PM–5:30 PM |
Regulatory Views on Use of DNA Adduct Data in Risk Assessment
Speaker: Rita Schoeny, U.S. Environmental Protection Agency |
| 6:00 PM–8:00 PM |
|
|
EMS Council Meeting |
|
|